Thanks for the response. I have a lot of tril. I like that one a lot. I think big pharma will want to partner with them but tril has a strong cash position so if they partner, the terms should be favorable to tril
Also picked up pirs which has partnerships with some big names but low float and their programs are early. Also like tbuff and cfrx. Cfrx has impressive manager and an interesting platform.